Production (Stage)
Microbot Medical Inc.
MBOT
$2.62
-$0.02-0.76%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 28.56% | 170.81% | 33.05% | 14.08% | -6.68% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 26.72% | 65.86% | 29.72% | 8.05% | -18.33% |
| Operating Income | -26.72% | -65.86% | -29.72% | -8.05% | 18.33% |
| Income Before Tax | -9.70% | -7.55% | -31.44% | -7.78% | 16.89% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -9.70% | -7.55% | -31.44% | -7.78% | 16.89% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.70% | -7.55% | -31.44% | -7.78% | 16.89% |
| EBIT | -26.72% | -65.86% | -29.72% | -8.05% | 18.33% |
| EBITDA | -27.59% | -67.44% | -29.83% | -8.66% | 18.59% |
| EPS Basic | 50.39% | 25.94% | 6.56% | 33.23% | 52.61% |
| Normalized Basic EPS | 44.40% | -14.48% | 6.58% | 33.20% | 52.63% |
| EPS Diluted | 50.39% | 25.94% | 6.56% | 33.23% | 53.14% |
| Normalized Diluted EPS | 44.40% | -14.48% | 6.58% | 33.20% | 52.63% |
| Average Basic Shares Outstanding | 121.16% | 45.18% | 40.69% | 61.40% | 75.41% |
| Average Diluted Shares Outstanding | 121.16% | 45.18% | 40.69% | 61.40% | 75.41% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |